Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity

No approved vaccines against respiratory syncytial virus (RSV) infections exist to date, due to challenges arising during vaccine development. There is an unmet need to explore novel approaches and a universal strategy to prevent RSV infections. Previous studies have proven the immune efficacy of vi...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Sa, Sucheta, Braz Gomes, Kimberly, Allotey-Babington, Grace Lovia, Boyoglu, Cemil, Kang, Sang-Moo, D’Souza, Martin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030121/
https://www.ncbi.nlm.nih.gov/pubmed/35455333
http://dx.doi.org/10.3390/vaccines10040584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030121/
https://www.ncbi.nlm.nih.gov/pubmed/35455333
http://dx.doi.org/10.3390/vaccines10040584

Ejemplares similares